97 related articles for article (PubMed ID: 15285879)
21. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
[TBL] [Abstract][Full Text] [Related]
22. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
23. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
24. High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.
Parker AS; Cheville JC; Janney CA; Cerhan JR
Hum Pathol; 2002 Aug; 33(8):801-5. PubMed ID: 12203212
[TBL] [Abstract][Full Text] [Related]
25. In situ detection of retinoid-X receptor expression in normal and psoriatic human skin.
Reichrath J; Münssinger T; Kerber A; Rochette-Egly C; Chambon P; Bahmer FA; Baum HP
Br J Dermatol; 1995 Aug; 133(2):168-75. PubMed ID: 7547381
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
28. The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors.
Lenko V; Bialesova L; Macejova D; Bujdak P; Breza J; Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):316-24. PubMed ID: 24077234
[TBL] [Abstract][Full Text] [Related]
29. Cyst-associated renal cell carcinoma: clinicopathologic characteristics and evaluation of prognosis in 27 cases.
Onishi T; Oishi Y; Goto H; Tomita M; Abe K; Sugaya S
Int J Urol; 2001 Jun; 8(6):268-74. PubMed ID: 11389741
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
31. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
32. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
May M; Brookman-Amissah S; Roigas J; Gilfrich CP; Pflanz S; Hoschke B; Gunia S
Urol Oncol; 2010; 28(3):274-9. PubMed ID: 18805709
[TBL] [Abstract][Full Text] [Related]
34. Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients.
Ikuerowo SO; Kuczyk MA; Mengel M; van der Heyde E; Shittu OB; Vaske B; Jonas U; Machtens S; Serth J
Int J Cancer; 2006 Aug; 119(4):867-74. PubMed ID: 16557593
[TBL] [Abstract][Full Text] [Related]
35. The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review.
Chen S; Zhu Y; Cui J; Wang Y; Xia Y; Song J; Cheng S; Zhou C; Zhang D; Zhang B; Shi B
Urol Oncol; 2017 Aug; 35(8):532.e15-532.e23. PubMed ID: 28427859
[TBL] [Abstract][Full Text] [Related]
36. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
37. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
[TBL] [Abstract][Full Text] [Related]
38. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
39. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M
BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
